Cargando…
P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566842/ http://dx.doi.org/10.1016/j.anai.2021.08.116 |
_version_ | 1784594103515742208 |
---|---|
author | Patel, J. Keshavarz, B. Richards, N. Workman, L. Muehling, L. Murphy, D. Eschenbacher, W. Nelson, M. Platts-Mills, T. Wilson, J. |
author_facet | Patel, J. Keshavarz, B. Richards, N. Workman, L. Muehling, L. Murphy, D. Eschenbacher, W. Nelson, M. Platts-Mills, T. Wilson, J. |
author_sort | Patel, J. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8566842 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85668422021-11-04 P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY Patel, J. Keshavarz, B. Richards, N. Workman, L. Muehling, L. Murphy, D. Eschenbacher, W. Nelson, M. Platts-Mills, T. Wilson, J. Ann Allergy Asthma Immunol Article Published by Elsevier Inc. 2021-11 2021-11-04 /pmc/articles/PMC8566842/ http://dx.doi.org/10.1016/j.anai.2021.08.116 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Patel, J. Keshavarz, B. Richards, N. Workman, L. Muehling, L. Murphy, D. Eschenbacher, W. Nelson, M. Platts-Mills, T. Wilson, J. P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY |
title | P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY |
title_full | P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY |
title_fullStr | P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY |
title_full_unstemmed | P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY |
title_short | P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY |
title_sort | p095 levels of igg to sars-cov-2 in recipients of covid-19 vaccines: longitudinal monitoring with quantitative assay |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566842/ http://dx.doi.org/10.1016/j.anai.2021.08.116 |
work_keys_str_mv | AT patelj p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay AT keshavarzb p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay AT richardsn p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay AT workmanl p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay AT muehlingl p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay AT murphyd p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay AT eschenbacherw p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay AT nelsonm p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay AT plattsmillst p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay AT wilsonj p095levelsofiggtosarscov2inrecipientsofcovid19vaccineslongitudinalmonitoringwithquantitativeassay |